Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun;12(6):556-63.
doi: 10.1200/JOP.2015.008946. Epub 2016 May 17.

Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials

Affiliations

Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials

Mona N Fouad et al. J Oncol Pract. 2016 Jun.

Abstract

Purpose: Less than 10% of patients enrolled in clinical trials are minorities. The patient navigation model has been used to improve access to medical care but has not been evaluated as a tool to increase the participation of minorities in clinical trials. The Increasing Minority Participation in Clinical Trials project used patient navigators (PNs) to enhance the recruitment of African Americans for and their retention in therapeutic cancer clinical trials in a National Cancer Institute-designated comprehensive cancer center.

Methods: Lay individuals were hired and trained to serve as PNs for clinical trials. African American patients potentially eligible for clinical trials were identified through chart review or referrals by clinic nurses, physicians, and social workers. PNs provided two levels of services: education about clinical trials and tailored support for patients who enrolled in clinical trials.

Results: Between 2007 and 2014, 424 African American patients with cancer were referred to the Increasing Minority Participation in Clinical Trials project. Of those eligible for a clinical trial (N = 378), 304 (80.4%) enrolled in a trial and 272 (72%) consented to receive patient navigation support. Of those receiving patient navigation support, 74.5% completed the trial, compared with 37.5% of those not receiving patient navigation support. The difference in retention rates between the two groups was statistically significant (P < .001). Participation of African Americans in therapeutic cancer clinical trials increased from 9% to 16%.

Conclusion: Patient navigation for clinical trials successfully retained African Americans in therapeutic trials compared with non-patient navigation trial participation. The model holds promise as a strategy to reduce disparities in cancer clinical trial participation. Future studies should evaluate it with racial/ethnic minorities across cancer centers.

PubMed Disclaimer

Figures

FIG 1.
FIG 1.
Referral rate to IMPaCT (Increasing Minority Participation in Clinical Trials) of African American patients with cancer.
FIG 2.
FIG 2.
Clinical trial and IMPaCT (Increasing Minority Participation in Clinical Trials) enrollment rates by year.

Comment in

References

    1. Corbie-Smith G, Miller WC, Ransohoff DF. Interpretations of ‘appropriate’ minority inclusion in clinical research. Am J Med. 2004;116:249–252. - PubMed
    1. Alexander-Bridges M, Doan LL. Commentary on “increasing minority participation in clinical research”: a white paper from the endocrine society. J Clin Endocrinol Metab. 2007;92:4557–4559. - PubMed
    1. Institute of Medicine Committee on Cancer Clinical Trials NCGP: A national cancer clinical trials system for the 21st century: Reinvigorating the NCI Cooperative Group Program. Washington, DC, National Academies Press, 2010. - PubMed
    1. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA. 2004;291:2720–2726. - PubMed
    1. Stewart JH, Bertoni AG, Staten JL, et al. Participation in surgical oncology clinical trials: Gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2007;14:3328–3334. - PubMed

Publication types